All work
Lets make uncontrollable epilepsy a thing of the past
Launching a world-first breakthrough in epilepsy management
The quick take
UNEEG medical engaged CBC to drive a fundamental shift in epilepsy care. This was not merely a product launch, but the introduction of a new standard: continuous, ultra long-term brain monitoring. EpiSight was positioned to reshape decision-making for specialists and transform daily life for people with uncontrolled epilepsy
About UNEEG medical
UNEEG medical specialises in pioneering cognitive technologies for collecting, monitoring and analysing EEG data in people with epilepsy. The company’s unique subcutaneous EEG solution for remote monitoring of brain activity was CE marked in 2019.
This groundbreaking technology enables the ultra long-term recording of seizures while wearers go about their daily lives. The solution provides the epileptic community with objective, longitudinal knowledge of seizure burdens, insights not possible with current tools. The second iteration of the breakthrough – the wireless UNEEG EpiSight solution – was launched in September 2024.
Scope
- Creative campaign concept
- Communications strategy including core story and messaging
- Photo and videoshoot incl model scouting
- Solution film for online media and sales support
- Sales support material targeting healthcare professionals
- Patient information aimed at people with epilepsy
- Online campaign elements incl. promotion and landing page
- Launch package (press material, event material, etc.)
The “Let’s make uncontrollable epilepsy a thing of the past” concept underlines the transformative potential of the UNEEG EpiSight solution for the entire epilepsy community.
Challenge
UNEEG needed to introduce EpiSight in a way that went beyond a conventional product launch and instead reshaped how long-term EEG monitoring is understood. The challenge was to engage a highly specialist, evidence-driven clinical audience while also communicating meaningful patient benefits to non-experts. At the same time, UNEEG had to build on existing solutions without creating confusion, and operate within strict MedTech regulations – requiring a clear, credible and strategically unified communication approach.
Solution
CBC developed a platform designed to reframe how epilepsy monitoring is understood, positioning UNEEG at the forefront of a new approach to long-term EEG. Built around the idea “Let’s make uncontrollable epilepsy a thing of the past,” the platform combined scientific credibility with a clear, human perspective. Communications were structured to engage both healthcare professionals and people with epilepsy, ensuring consistency while addressing different needs, and establishing UNEEG as a thought leader in this emerging category.
Challenge
Solution
UNEEG needed to introduce EpiSight in a way that went beyond a conventional product launch and instead reshaped how long-term EEG monitoring is understood. The challenge was to engage a highly specialist, evidence-driven clinical audience while also communicating meaningful patient benefits to non-experts. At the same time, UNEEG had to build on existing solutions without creating confusion, and operate within strict MedTech regulations – requiring a clear, credible and strategically unified communication approach.
CBC developed a platform designed to reframe how epilepsy monitoring is understood, positioning UNEEG at the forefront of a new approach to long-term EEG. Built around the idea “Let’s make uncontrollable epilepsy a thing of the past,” the platform combined scientific credibility with a clear, human perspective. Communications were structured to engage both healthcare professionals and people with epilepsy, ensuring consistency while addressing different needs, and establishing UNEEG as a thought leader in this emerging category.
A new homepage for positions EpiSight as a paradigm shift in epilepsy management, while also providing sufficient technical details and benefits for a specialist clinical audience.
CBC produced a brochure to give busy healthcare professionals an overview of the solution, with a clear visual explanation of how EEG data flows from wearers to treating physicians.
We also produced an easy-to-understand brochure to educate potential wearers of the solution – and pre-emptively address any concerns they may have about privacy, comfort, etc.
“The CBC launch campaign strikes the perfect balance. It resonates with technically savvy healthcare professionals, and connects with people with epilepsy – all while remaining true to our brand.”
Birgitte Gert Nielsen
Director Marketing & Product Management
Director Marketing & Product Management
